Novavax Inc. buy jomobb
Start price
28.05.21
/
80%
€125.18
Target price
28.05.22
€200.00
Performance (%)
-35.69%
End price
29.01.22
€80.50
Summary
This prediction ended on 29.01.22 with a price of €80.50. Massive losses of -35.69% were the result for the BUY prediction by jomobb. jomobb has 80% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Novavax Inc. | -0.381% | -0.381% | -21.362% |
iShares Core DAX® | 2.149% | 5.415% | 21.385% |
iShares Nasdaq 100 | 0.838% | 1.926% | 44.386% |
iShares Nikkei 225® | 1.143% | 2.887% | 27.641% |
iShares S&P 500 | 1.265% | 3.698% | 33.327% |
According to jomobb what are the pros and cons of Novavax Inc. for the foreseeable future?
Pros
Top 10 in its market
Very Future proof/growth oriented business model
Leading role in innovation
Some uniques
Cons
Significant cyclical dependencies
Comments by jomobb for this prediction
In the thread Novavax Inc. diskutieren
Kombi-Impfstoff